SCHEMBL9824898

SCHEMBL9824898

COc1cc(CCNC(C)Cc2cc(OC)ccc2/C=C\c2ccccc2)cc(OC)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC2A1 P11166 2/20 0.50
CYP1A2 P05177 6/20 0.46
CYP1A1 P04798 5/20 0.46
CYP1B1 Q16678 5/20 0.46
SIGMAR1 Q99720 3/20 0.44
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
HTT P42858 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
CYP3A4 P08684 2/20 0.39
CYP2C19 P33261 2/20 0.39
CYP2E1 P05181 1/20 0.39
CYP2C8 P10632 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2A6 P11509 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP4B1 P13584 1/20 0.39
CYP2B6 P20813 1/20 0.39
CYP3A5 P20815 1/20 0.39
CYP2A7 P20853 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9824627 1.00 SLC2A1 (0.50) SLC2A1CYP1A2CYP1A1CYP1B1SIGMAR1
SCHEMBL9824526 1.00 SLC2A1 (0.50) SLC2A1CYP1A2CYP1A1CYP1B1SIGMAR1
SCHEMBL10759050 0.88 SLC2A1 (0.49) SLC2A1CYP1A2CYP1A1CYP1B1SIGMAR1
SCHEMBL9824630 0.88 SLC2A1 (0.49) SLC2A1CYP1A2CYP1A1CYP1B1SIGMAR1
SCHEMBL9824503 0.88 SLC2A1 (0.49) SLC2A1CYP1A2CYP1A1CYP1B1SIGMAR1
SCHEMBL9824522 0.87 SLC2A1 (0.48) SLC2A1CYP1A2CYP1A1CYP1B1SIGMAR1
Hydrochloric Acid SCHEMBL9824621 0.87 SLC2A1 (0.48) SLC2A1CYP1A2CYP1A1CYP1B1SIGMAR1
Hydrochloric Acid SCHEMBL9824367 0.87 SLC2A1 (0.48) SLC2A1CYP1A2CYP1A1CYP1B1SIGMAR1
SCHEMBL9824218 0.87 SLC2A1 (0.48) SLC2A1CYP1A2CYP1A1CYP1B1SIGMAR1
SCHEMBL9825013 0.85 CYP1A1 (0.44) SLC2A1CYP1A2CYP1A1CYP1B1SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0250254-A1 Cis & trans stilbenes and their composition for the treatment of hypertension McNeilab, Inc. (US) 1987-12-23 EP claimed
EP-0250254-B1 CIS & TRANS STILBENES AND THEIR COMPOSITION FOR THE TREATMENT OF HYPERTENSION McNeilab, Inc. (US) 1991-06-19 EP disclosed
EP-0250254-A1 Cis & trans stilbenes and their composition for the treatment of hypertension McNeilab, Inc. (US) 1987-12-23 EP disclosed